Skip to main content
Back to News

News From Around the System

UCI Health clinical trial targets recurrent AML

UCI Health — July 14, 2020

The UCI Health Chao Family Comprehensive Cancer has launched a first-in-the-nation clinical trial combining two recently approved drugs to prevent recurrence of adult acute myeloid leukemia (AML) in patients with myelodysplastic changes or therapy-related AML. The investigator-initiated clinical trail led by oncologist Dr. Deepa Jeyakumar is adding the stem-cell drug…

Current Clinical Trial Assessing Potential of CBD in Treatment of Autism

UC San Diego Health — July 14, 2020

Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.

Human Sperm Stem Cells Grown in Lab, an Early Step Toward Infertility Treatment

UC San Diego Health — July 13, 2020

Infertility affects one in seven men of reproductive age worldwide. One idea for treating male sterility is spermatogonial stem cell (SSC) therapy. In this approach, sperm stem cells in the testis are transferred to a test tube, cultured and nudged into becoming fully fledged sperm. However, a key...

UCI Health doctor answers COVID-19 questions on ABC7

UCI Health — July 1, 2020

IN THE NEWS: Dr. Jose Mayorga, director of the UCI Health Family Health Center Santa Ana, tells ABC7 viewers how best to protect themselves from the virus that causes COVID-19. In the "Ask the Doctor" panel discussion, Mayorga explains the importance of proper hand hygiene and the use of masks…

UCI Health urges extra caution for July 4th gatherings as COVID-19 numbers rise

UCI Health — June 30, 2020

UCI Health infectious diseases experts urge the public to use extra caution over the July 4 holiday weekend as Orange County experiences a significant jump in the COVID-19-related cases, hospitalizations and deaths. They recommend: Wearing masks in public places Keeping at least six feet from others Observing hand hygiene Socializing…

Universal Gut Microbiome-Derived Signature Predicts Cirrhosis

UC San Diego Health — June 30, 2020

UC San Diego School of Medicine researchers report that stool microbiomes of NAFLD patients are distinct enough to potentially be used to accurately predict which persons with NAFLD are at greatest risk for having cirrhosis.

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts